Phase I/IIa European trial of Tribetarna in patients with drug-resistant non-small cell lung cancer.

Trial Profile

Phase I/IIa European trial of Tribetarna in patients with drug-resistant non-small cell lung cancer.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 08 Jul 2013

At a glance

  • Drugs Tribetarna (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Jul 2013 Planned initiation date changed to 1 Dec 2014.
    • 27 Jun 2013 New trial record
    • 03 Jun 2013 This trial is planned to commence in the fourth quarter of 2014, according to a Benitec Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top